½ÃÀ庸°í¼­
»óǰÄÚµå
1604647

¼¼°èÀÇ ¾î·¹ÀÌ Àåºñ ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Array Instruments Market by Technology (Cellular Microarrays, DNA Microarrays, Protein Microarrays), End-User (Clinical Diagnostics Laboratories, Forensic Centers, Research & Development Laboratories) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾î·¹ÀÌ Àåºñ(Array Instruments) ½ÃÀåÀº 2023³â¿¡ 13¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 13¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤ µÇ¸ç, CAGR 6.10%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 19¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

360iResearchÀÇ ½ÃÀå Á¶»ç ºÐ¼®°¡·Î¼­ ¾î·¹ÀÌ Àåºñ´Â °úÇÐ ¿¬±¸¿Í »ê¾÷ ÀÀ¿ë ºÐ¾ß¿¡¼­ ¿©·¯ ºÐ¼® ´ë»óÀ» µ¿½Ã¿¡ ºÐ¼®ÇÏ´Â ÀåÄ¡¸¦ Æ÷°ýÇÏ´Â ¹üÀ§¿Í Á¤ÀÇ¿¡ ´ëÇÑ Æ÷°ýÀûÀÎ ÀÌÇØ¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, ¾à¹° ¹ß°ß, Áø´Ü°ú °°Àº ºÐ¾ß¿¡¼­ Áß¿äÇÑ °í󸮷® µ¥ÀÌÅÍ ¼öÁý¿¡ ÇÊ¿äÇÕ´Ï´Ù. ÃÖÁ¾ »ç¿ë ¹üÀ§´Â Á¦¾à, »ý¸í°øÇÐ, ½Äǰ ¾ÈÀü, ȯ°æ ¸ð´ÏÅ͸µ, ÀÓ»ó ¿¬±¸ µî ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡ °ÉÃÄ ÀÖÀ¸¸ç, ºÐ¼®ÀÇ Á¤È®¼º°ú È¿À²¼ºÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ½ÃÀåÀÇ ¿øµ¿·Â¿¡´Â ±â¼ú ¹ßÀü, °³ÀÎ ¸ÂÃãÇü ÀÇÇп¡ ´ëÇÑ ¼ö¿ä Áõ°¡, È¿À²ÀûÀ̰í Á¤¹ÐÇÑ ºÐ¼® ±â¼ú¿¡ ´ëÇÑ Çʿ伺 Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ÇöÀç ÀáÀçÀûÀÎ ±âȸ´Â µðÁöÅÐ º¯È¯°ú µ¥ÀÌÅÍ ºÐ¼®¿¡ ÀΰøÁö´ÉÀ» ÅëÇÕÇÏ¿© ½ÅÈï ½ÃÀå¿¡¼­ ÀÀ¿ë ºÐ¾ß¸¦ È®ÀåÇÏ´Â µ¥ ÀÖÀ¸¸ç, ÀÌ´Â °æÀï ¿ìÀ§¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ºñ¿ë, µ¥ÀÌÅÍ °ü¸®ÀÇ º¹À⼺, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä±¸ »çÇ× µîÀÇ µµÀü °úÁ¦´Â ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â±âÀÇ Ç¥ÁØÈ­ ¹× »óÈ£ ¿î¿ë¼ºÀÇ ÇѰè´Â ±¤¹üÀ§ÇÑ Ã¤Åÿ¡ Àå¾Ö¹°ÀÌ µË´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí Çõ½ÅÀÌ ¼º¼÷ÇÑ ºÐ¾ß¿¡´Â ºñ¿ë È¿À²ÀûÀÌ°í ¼ÒÇüÈ­µÈ ±â±âÀÇ °³¹ß, ¿öÅ©Ç÷οìÀÇ ÀÚµ¿È­ Çâ»ó, ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» ÅëÇÑ µ¥ÀÌÅÍ ºÐ¼® ´É·Â Çâ»ó µîÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀåÀº Áö¼ÓÀûÀÎ Çõ½Å°ú Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÀÇÇØ ¿ªµ¿ÀûÀÌ°í °æÀï·Â ÀÖ´Â ¼º°ÝÀ» ¶ì°í ÀÖ½À´Ï´Ù. ±â¾÷Àº »ç¿ëÀÚ À¯¿¬¼ºÀ» ³ôÀÌ°í ¼º´É ½Å·Ú¼ºÀ» ³ôÀÌ¸ç µ¥ÀÌÅÍ º¸¾È ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿¬±¸¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. »ê¾÷ °£ Çù¾÷¿¡ Âü¿©ÇÏ¸é ¹ÌÃæÁ· ¿ä±¸¸¦ ÃæÁ·½ÃŰ´Â Çõ½ÅÀ» ÃËÁøÇÏ¿© ÀÌ ÁøÈ­Çϴ ȯ°æ¿¡¼­ ¸®´õ½ÊÀ» È®°íÈ÷ ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ±ÞÁõÇÏ´Â ¼ö¿ä¿Í ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ¾î·¹ÀÌ ÀνºÆ®·ç¸ÕÆ®´Â º¹ÀâÇÑ ½ÃÀå ¹®Á¦¿¡µµ ºÒ±¸ÇÏ°í ¾÷°è ¿ª·®À» ¹ßÀü½ÃŰ´Â µ¥ Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 13¾ï 1,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 13¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 19¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 6.10%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾î·¹ÀÌ Àåºñ ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

¾î·¹ÀÌ Àåºñ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÇÏ´Â ½ÃÀå ¿ªÇÐÀ» ÀÌÇØÇÏ¸é ºñÁî´Ï½º Á¶Á÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû °áÁ¤À» ±¸Ã¼È­Çϸç, »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ºñÁî´Ï½º Á¶Á÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÏ´Â µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å Æ®·»µå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º ÁúȯÀÇ Áø´Ü°ú ¿¹ÈÄ ¿¹Ãø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ÁÖ¹®Á¦ÀÛÀǾàǰ°ú ½Å¾à °³¹ß¿¡ ´ëÇÑ ¼ö¿äÀÇ ±ÞÁõ
    • °¨¿°ÁõÀÇ À¯Çà Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºÐ¼® ¹× µ¥ÀÌÅÍ ¼öÁý¿¡ ½Ã°£ÀÌ °É¸®´Â °Í°ú ¾î·¹ÀÌ ÀåºñÀÇ ºñ¿ëÀÌ ³ôÀº °Í
  • ½ÃÀå ±âȸ
    • ¾î·¹ÀÌ ±â¼úÀÇ ±â¼úÀû Áøº¸
    • À¯ÀüüÇÐ¿Í ´Ü¹éÁúüÇÐ Áøº¸
  • ½ÃÀå °úÁ¦
    • °á°úÀÇ Ç¥ÁØÈ­¿Í ÀçÇö¼º¿¡ °üÇÑ ¹®Á¦

Porter's Five Forces : ¾î·¹ÀÌ Àåºñ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷ÀÌ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾î·¹ÀÌ Àåºñ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾î·¹ÀÌ Àåºñ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾î·¹ÀÌ Àåºñ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¾î·¹ÀÌ Àåºñ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï ¿ìÀ§¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¾î·¹ÀÌ Àåºñ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾î·¹ÀÌ Àåºñ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Àü·« ºÐ¼® ¹× Á¦¾È : ¾î·¹ÀÌ Àåºñ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¾î·¹ÀÌ Àåºñ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº Àü ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º ÁúȯÀÇ Áø´Ü°ú ¿¹ÈÄ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • ÁÖ¹®À» ¹Þ¾Æ¼­ ¸¸µé¾îÁø ÀǾàǰ°ú ½Å¾à °³¹ß ¼ö¿äÀÇ ±ÞÁõ
      • °¨¿°ÁõÀÇ ¸¸¿¬ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ¾î·¹ÀÌ ±â±âÀÇ °íºñ¿ë°ú ½Ã°£ÀÌ °É¸®´Â ºÐ¼® ¹× µ¥ÀÌÅÍ ¼öÁý
    • ±âȸ
      • ´Ù¾çÇÑ ±â¼ú Áøº¸
      • À¯ÀüüÇÐ¿Í ´Ü¹éÁúüÇÐ Áøº¸
    • °úÁ¦
      • °á°úÀÇ Ç¥ÁØÈ­¿Í ÀçÇö¼º¿¡ °üÇÑ ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå ¾î·¹ÀÌ Àåºñ ½ÃÀå : ±â¼úº°

  • ¼¼Æ÷ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • DNA ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • ´Ü¹éÁú ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • Á¶Á÷ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ

Á¦7Àå ¾î·¹ÀÌ Àåºñ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÀÓ»ó Áø´Ü ½ÇÇè½Ç
  • ¹ýÀÇÇÐ ¼¾ÅÍ
  • ¿¬±¸°³¹ß¿¬±¸¼Ò

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾î·¹ÀÌÀåºñ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¾î·¹ÀÌ Àåºñ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾î·¹ÀÌ Àåºñ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Acolyte Instruments
  • Agilent Technologies, Inc.
  • ArC INSTRUMENTS
  • Arrayit Corporation
  • Arrayjet Ltd.
  • Bio SB Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Biolabs
  • Evident Corporation
  • Grace Bio-Labs
  • Illumina, Inc.
  • INNOPSYS
  • Macrogen, Inc.
  • MESO SCALE DIAGNOSTICS, LLC
  • Molecular Devices, LLC
  • Native Instruments GmbH
  • OriGene Technologies, Inc.
  • Oxford Gene Technology IP Limited
  • PerkinElmer Inc.
  • Phalanx Biotech Group
  • QIAGEN GMBH
  • RayBiotech Life, Inc.
  • Retrogenix by Charles River Laboratories
  • Thermo Fisher Scientific Inc.
  • Z-Check Corporation
LYJ

The Array Instruments Market was valued at USD 1.31 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 6.10%, to USD 1.99 billion by 2030.

As a Market Research Analyst at 360iResearch, the focus on Array Instruments involves a comprehensive understanding of its scope and definition, which encompasses devices used in scientific research and industrial applications for analyzing multiple analytes simultaneously. These instruments are necessary for high-throughput data collection, which is critical in areas like genomics, proteomics, drug discovery, and diagnostics. The end-use scope spans various industries, including pharmaceuticals, biotechnology, food safety, environmental monitoring, and clinical research, where accuracy and efficiency in analysis are paramount. The market's driving forces include technological advancements, increasing demand for personalized medicine, and the growing need for efficient and precise analytical techniques. Currently, potential opportunities lie in expanding applications in emerging markets, augmented by digital transformation and integration of artificial intelligence in data analytics, which can provide competitive advantages. However, challenges such as high costs, the complexity of data management, and stringent regulatory requirements can impede growth. Additionally, limitations in standardization and interoperability of instruments pose hurdles in achieving widespread adoption. Nevertheless, areas ripe for innovation include the development of cost-effective and miniaturized devices, enhancing automation in workflows, and improving data analysis capabilities through machine learning algorithms. The market exhibits a dynamic and competitive nature, driven by continuous innovation and strategic partnerships. Companies should focus on research that enhances user flexibility, improves performance reliability, and addresses data security concerns to stay ahead. Engaging in cross-industry collaborations can also spur breakthroughs that cater to unmet needs, solidifying leadership in this evolving landscape. Overall, the burgeoning demand, coupled with technological progress, positions Array Instruments as a critical component in advancing industry capabilities, despite encountering intricate market challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 1.31 billion
Estimated Year [2024] USD 1.39 billion
Forecast Year [2030] USD 1.99 billion
CAGR (%) 6.10%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Array Instruments Market

The Array Instruments Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased demand for the diagnosis and prognosis of chronic diseases
    • Surge in demand for customized medications and drug discovery
    • Rising prevalence of infectious disease
  • Market Restraints
    • High cost of array instrument coupled with time-consuming analysis and data collection
  • Market Opportunities
    • Technological advancements in an array technologies
    • Advancements in genomics and proteomics
  • Market Challenges
    • Issues related to standardization and reproducibility of results

Porter's Five Forces: A Strategic Tool for Navigating the Array Instruments Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Array Instruments Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Array Instruments Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Array Instruments Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Array Instruments Market

A detailed market share analysis in the Array Instruments Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Array Instruments Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Array Instruments Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Array Instruments Market

A strategic analysis of the Array Instruments Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Array Instruments Market, highlighting leading vendors and their innovative profiles. These include Acolyte Instruments, Agilent Technologies, Inc., ArC INSTRUMENTS, Arrayit Corporation, Arrayjet Ltd., Bio SB Inc., Bio-Rad Laboratories, Inc., Creative Biolabs, Evident Corporation, Grace Bio-Labs, Illumina, Inc., INNOPSYS, Macrogen, Inc., MESO SCALE DIAGNOSTICS, LLC, Molecular Devices, LLC, Native Instruments GmbH, OriGene Technologies, Inc., Oxford Gene Technology IP Limited, PerkinElmer Inc., Phalanx Biotech Group, QIAGEN GMBH, RayBiotech Life, Inc., Retrogenix by Charles River Laboratories, Thermo Fisher Scientific Inc., and Z-Check Corporation.

Market Segmentation & Coverage

This research report categorizes the Array Instruments Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Cellular Microarrays, DNA Microarrays, Protein Microarrays, and Tissue Microarrays.
  • Based on End-User, market is studied across Clinical Diagnostics Laboratories, Forensic Centers, and Research & Development Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased demand for the diagnosis and prognosis of chronic diseases
      • 5.1.1.2. Surge in demand for customized medications and drug discovery
      • 5.1.1.3. Rising prevalence of infectious disease
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of array instrument coupled with time-consuming analysis and data collection
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in an array technologies
      • 5.1.3.2. Advancements in genomics and proteomics
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to standardization and reproducibility of results
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Array Instruments Market, by Technology

  • 6.1. Introduction
  • 6.2. Cellular Microarrays
  • 6.3. DNA Microarrays
  • 6.4. Protein Microarrays
  • 6.5. Tissue Microarrays

7. Array Instruments Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinical Diagnostics Laboratories
  • 7.3. Forensic Centers
  • 7.4. Research & Development Laboratories

8. Americas Array Instruments Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Array Instruments Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Array Instruments Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acolyte Instruments
  • 2. Agilent Technologies, Inc.
  • 3. ArC INSTRUMENTS
  • 4. Arrayit Corporation
  • 5. Arrayjet Ltd.
  • 6. Bio SB Inc.
  • 7. Bio-Rad Laboratories, Inc.
  • 8. Creative Biolabs
  • 9. Evident Corporation
  • 10. Grace Bio-Labs
  • 11. Illumina, Inc.
  • 12. INNOPSYS
  • 13. Macrogen, Inc.
  • 14. MESO SCALE DIAGNOSTICS, LLC
  • 15. Molecular Devices, LLC
  • 16. Native Instruments GmbH
  • 17. OriGene Technologies, Inc.
  • 18. Oxford Gene Technology IP Limited
  • 19. PerkinElmer Inc.
  • 20. Phalanx Biotech Group
  • 21. QIAGEN GMBH
  • 22. RayBiotech Life, Inc.
  • 23. Retrogenix by Charles River Laboratories
  • 24. Thermo Fisher Scientific Inc.
  • 25. Z-Check Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦